Stay updated on Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.

Latest updates to the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page
- Check4 days agoChange DetectedThe page revision label changed from v3.6.2 to v3.6.3, reflecting an updated version of the page content.SummaryDifference0.0%

- Check11 days agoChange DetectedThe study page now shows revision v3.6.2, replacing v3.6.0, indicating a minor, non-content update to how the page is rendered or tracked.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRecruitment status on the study page has been updated to indicate enrollment is closed ('No longer looking for participants'). New guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention label formatting was adjusted, with a new page revision version.SummaryDifference0.4%

- Check32 days agoChange DetectedThe page footer updated its revision number from v3.5.4 to v3.5.5, representing a small site update; no visible content changes to the study details or layout.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's revision metadata.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page’s revision identifier was updated from v3.5.2 to v3.5.3, reflecting a platform/version update rather than substantive study content changes.SummaryDifference0.0%

Stay in the know with updates to Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.